MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202611075290 A) filed by Noida Institute Of Engineering And Technology Niet on June 18, 2026, for Placenta-Targeted Aspirin Nanoconjugates For Restoring Angiogenic Balance In Foetal Growth Restriction.
Inventors include Dr. Saumya Das; and Dr. Avijit Mazumder.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: The present invention discloses a self-assembling aspirin-RGDS tetrapeptide nanoconjugate for placenta-targeted treatment of foetal growth restriction. The conjugate comprises an acetylsalicyloyl moiety covalently linked to the RGDS peptide, forming carrier-free nanostructures of approximately 1...